Pediatrix Medical Group Reports Q3 Adjusted EBITDA of $85 Million and Narrows 2026 Outlook
Pediatrix Medical Group (MD) reported a strong third quarter, highlighted by an adjusted EBITDA of $85 million. The company noted positive same-unit revenue growth, driven by balanced contributions across its service segments. Looking ahead to 2026, management has narrowed its adjusted EBITDA guidance to a range of $290 million to $300 million. Additionally, the company's share repurchase program has reached a significant milestone, with 10 million shares bought back to date.
Tickers: $MD
Topics: earnings EBITDA revenue growth
Read the full article at Seeking Alpha
Part of the story Cloudflare Shares Surge Following Strong Q3 Results and Raised Full-Year Guidance (85 articles)